Panel discussion - Improving CV outcomes in type 2 diabetes: A novel role for GLP-1 receptor agonists?
Session:
Improving cardiovascular outcomes in type 2 diabetes: a novel role for GLP-1 receptor agonists?
Topic:
Diabetes, dysglycaemia and metabolic syndrome
Speaker:
Professor L. Ryden (Stockholm, SE)
Doctor J. Plutzky (Boston, US)
Professor N. Poulter (London, GB)
Sponsored by Novo Nordisk
Event:
ESC Congress 2017
Congress Presentation
About the speakers
Professor Lars Ryden
Karolinska Institute, Stockholm (Sweden)
37
presentations
1
follower
Doctor Jorge Plutzky
Brigham and Women's Hospital, Boston (United States of America)
5
presentations
0
follower
Professor Neil Poulter
Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
27
presentations
0
follower
4 more presentations in this session
Access the full session
Improving cardiovascular outcomes in type 2 diabetes: a novel role for GLP-1 receptor agonists?
Speakers:
Professor L. Ryden, Doctor J. Plutzky, Professor N. Poulter, Professor L. Ryden, Doctor J. Plutzky...
About the event
ESC 365 is supported by
